Results 121 to 130 of about 88,938 (144)

Associations between medication beliefs and medication adherence among inpatients with chronic obstructive pulmonary disease: a cross-sectional survey. [PDF]

Front Public Health
Li H, Wang N, Zhang L, Shi J, Jia X.
europepmc   +1 more source

Primary Hyperhidrosis: A Review of Epidemiology, Pathophysiology and Management. [PDF]

Acta Derm Venereol
Shayesteh A.
europepmc   +1 more source

Achieving clinical remission in moderate-to-severe asthma using inhaled triple therapy. [PDF]

ERJ Open Res
Canonica GW, Singh D, Papi A, Brusselle G, Piraino A, Franzini L, Vele A, Hernandez G, Skloot G, Virchow JC.   +9 more
europepmc   +1 more source

Once-daily glycopyrronium bromide (Seebri Breezhaler®) for the treatment of chronic obstructive pulmonary disease (COPD)

Expert Opinion on Pharmacotherapy, 2015
Introduction: Long-acting bronchodilators are the mainstay of pharmacological therapy for patients with chronic obstructive pulmonary disease (COPD). The choice of optimal bronchodilator therapy for COPD is increasingly difficult for clinicians as new ...
Charlotte Suppli Ulrik
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Synthesis of C-14 labeled Rac-(3R,2S)-glycopyrronium bromide

Journal of Labelled Compounds and Radiopharmaceuticals, 2020
Linda Thunberg, Charles S. Elmore, Jonas Bergare   +2 more
exaly  

Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma

Current Respiratory Medicine Reviews, 2022
Alberto A Papi, Konstantinos Kostikas, Ivan Nikolaev   +2 more
exaly